Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,265 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
Harrington J, Carnicelli AP, Hua K, Wallentin L, Patel MR, Hohnloser SH, Giugliano RP, Fox KAA, Hijazi Z, Lopes RD, Pokorney SD, Hong H, Granger CB. Harrington J, et al. Among authors: patel mr. Circulation. 2023 Jun 6;147(23):1748-1757. doi: 10.1161/CIRCULATIONAHA.122.062752. Epub 2023 Apr 12. Circulation. 2023. PMID: 37042255
The search for myocardial protection: is there still hope?
Granger CB, Patel MR. Granger CB, et al. Among authors: patel mr. J Am Coll Cardiol. 2007 Jul 31;50(5):406-8. doi: 10.1016/j.jacc.2007.02.074. Epub 2007 Jul 16. J Am Coll Cardiol. 2007. PMID: 17662391 Free article. No abstract available.
Rivaroxaban, an oral direct factor Xa inhibitor.
Piccini JP, Patel MR, Mahaffey KW, Fox KA, Califf RM. Piccini JP, et al. Among authors: patel mr. Expert Opin Investig Drugs. 2008 Jun;17(6):925-37. doi: 10.1517/13543784.17.6.925. Expert Opin Investig Drugs. 2008. PMID: 18491993 Review.
Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
Patel MR, Pfisterer ME, Betriu A, Widmisky P, Holmes DR Jr, O'Neill WW, Stebbins A, Van de Werf F, Armstrong PW, Granger CB; APEX-AMI Investigators. Patel MR, et al. Am J Cardiol. 2009 Jan 15;103(2):181-6. doi: 10.1016/j.amjcard.2008.08.066. Epub 2008 Nov 7. Am J Cardiol. 2009. PMID: 19121433 Clinical Trial.
Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Jolicoeur EM, O'Neill WW, Hellkamp A, Hamm CW, Holmes DR Jr, Al-Khalidi HR, Patel MR, Van de Werf FJ, Pieper K, Armstrong PW, Granger CB; APEX-AMI Investigators. Jolicoeur EM, et al. Among authors: patel mr. Eur Heart J. 2009 Nov;30(21):2575-83. doi: 10.1093/eurheartj/ehp279. Epub 2009 Jul 11. Eur Heart J. 2009. PMID: 19596659 Clinical Trial.
Detection of myocardial damage in patients with sarcoidosis.
Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW, Judd RM, Kim RJ. Patel MR, et al. Circulation. 2009 Nov 17;120(20):1969-77. doi: 10.1161/CIRCULATIONAHA.109.851352. Epub 2009 Nov 2. Circulation. 2009. PMID: 19884472 Free PMC article. Clinical Trial.
Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
Patel MR, Worthley SG, Stebbins A, Dill T, Rademakers FE, Valeti US, Barsness GW, Van de Werf F, Hamm CW, Armstrong PW, Granger CB, Kim RJ. Patel MR, et al. JACC Cardiovasc Imaging. 2010 Jan;3(1):52-60. doi: 10.1016/j.jcmg.2009.09.014. Epub 2010 Jan 12. JACC Cardiovasc Imaging. 2010. PMID: 20129531 Free article. Clinical Trial.
1,265 results